Kathy Yi - 06 Oct 2021 Form 4 Insider Report for Theseus Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Bradford Dahms - Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
06 Oct 2021
Net transactions value
$0
Form type
4
Filing time
08 Oct 2021, 19:00:20 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRX Stock Option (right to buy) Award $0 +22,678 $0.000000 22,678 06 Oct 2021 Common Stock 22,678 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/36th of the options vesting monthly after October 6, 2021, subject to the Reporting Person's continuous service with the issuer.